Advisory Board
Mr. Anand Khedkar,
Director,
Sekkei Bio
Mr. Khedkar is currently the director and co-founder of Sekkei Bio Private Limited. Sekkei Bio was founded with a vision to establish a disruptive biologics discovery company, he has spearheaded the development of cutting-edge technologies over the past six years. With a PhD in Protein Formulation and 27 years of experience in the life sciences industry, his expertise spans the Chemistry, Manufacturing, and Controls (CMC) value chain in the area of viral vector vaccine technology for SARS CoV-2, biosimilar products, innovator of oral insulin tregopil.
Mr. Avinash Verma,
Principal Expert Cold Chain for Vaccines,
UN Environment Program
Avinash is a seasoned expert for vaccines with nearly 20 years of industry experience. His expertise spans global pharmaceutical regulations including Good Clinical Practice, Good Manufacturing Practice, and Drug Supply Chain Security. He is a Subject Matter Expert in pharmaceuticals, biotech, vaccines, clinical trials, and more. With certifications in ESG and extensive qualifications including an MBA in International Business, he excels in R&D, program management, and supply chain operations.
Dr. Jeevan Ghosalkar,
Head of Discovery Biology,
Cipla R&D Centre
Dr. Jeevan Ghosalkar, with over 23 years in biopharmaceutical research, currently serves as the Director and Head of Discovery Biology at Cipla R&D Centre. An accomplished preclinical drug discovery scientist, his expertise spans oncology, autoimmune diseases, pulmonary hypertension, and infectious diseases. Dr. Ghosalkar has developed significant assays for drug efficacy and toxicity, contributing to Cipla’s first COVID-19 rapid diagnostic kit. His leadership extends to intellectual property, with 22 US patents co-authored. His contributions have propelled advancements in drug development and diagnostics, showcasing his profound impact on pharmaceutical innovations.global patents and presented numerous articles at prestigious events such as the AACR (American Association for Cancer Research) gatherings.
Dr. Venkata Indurthi,
CSO,
Aldevron
Dr. Venkata Indurthi is a recognised scientific leader in the nucleic acid (plasmid DNA and mRNA) and recombinant protein manufacturing space. He currently serves as the chief scientific officer at Aldevron, one of the world’s leading manufacturers of nucleic acids. He is one of the pioneers in the field of mRNA manufacturing and his work in the field of nucleic acid manufacturing has impacted various novel cell and gene therapies(CGT) and vaccines. He is a key thought leader in the genomics medicine space and has played a vital role in the advancement of various therapies and vaccines.